Lipocine LPCN 深 沪
交易中 09-22 10:47:32 美东时间
2.88
0.000
0.00%
华盛通- 最 高2.88
- 今 开2.86
- 成交量 850股
- 最 低 2.8548
- 昨 收 2.88
- 总市值 1560.67万
- 52周最高 6.1683
- 市盈率 静 --
- 换手率 0.02%
- 52周最低 2.6838
- 委 比 -48.15%
- 总股本 541.90万
- 历史最高 340.00
- 量 比 0.47
- 振 幅 0.88%
- 历史最低 2.6838
- 每 手 1
- 风险率 0.90%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Outlook For Aytu BioPharma
Aytu BioPharma (NASDAQ:AYTU) is preparing to release its quarterly earnings on ...
45分钟前
Lipocine Participates in H.C. Wainwright Investor Conference
Lipocine ( ($LPCN) ) has shared an update. Lipocine announced its participation...
09-05 23:17
Lipocine Announces LPCN 2101 Abstracts Accepted for Presentation at AES 2025
SALT LAKE CITY, Aug. 26, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with eff...
08-26 20:00
HC Wainwright & Co. Reiterates Buy on Lipocine, Maintains $8 Price Target
HC Wainwright & Co. analyst Yi Chen reiterates Lipocine (NASDAQ:LPCN) with a Buy and maintains $8 price target.
08-20 21:11
Lipocine Q2 EPS $(0.41) Misses $(0.40) Estimate, Sales $622.849M Beat $229.000K Estimate
Lipocine (NASDAQ:LPCN) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.40) by 2.5 percent. This is a 26.79 percent increase over losses of $(0.56) per share from the same
08-05 20:17
Lipocine Hosts Virtual Event on LPCN 1154
The latest update is out from Lipocine ( ($LPCN) ). On July 9, 2025, Lipocine h...
07-09 23:28
Lipocine Updates Corporate Presentation for Investors
Lipocine ( ($LPCN) ) just unveiled an announcement. Lipocine has updated its co...
07-02 23:48
Lipocine Begins Phase 3 Trial for LPCN 1154
An announcement from Lipocine ( ($LPCN) ) is now available. On June 26, 2025, L...
06-26 21:57
Lipocine to Host R&D Event on July 9
Lipocine ( ($LPCN) ) has provided an update. Lipocine Inc. announced it will ho...
06-24 02:57
美股大行评级 | 潜在涨幅434.95%！VNRX获Jones Trading首予"买入"评级，目标价3美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1139478829918380033.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持Metsera(MTSR)"买入"评级，目标价从56美元升至62美元</p> <p>• 摩根大通：维持Avidity Biosciences(RNA)"超配"评级，目标价从57美元升至59美元</
06-11 09:43
